Freightos HR VP sells shares at $0.79 to cover taxes

The reported sales were tied to tax liabilities from vesting restricted share units; the report also lists two direct stock-option holdings.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Freightos Ltd (CRGO) VP, Human Resources Sesma Andrea Indave reported selling 688 ordinary shares and 971 ordinary shares on October 16, 2026, each at $0.79 per share. Both sales were made on the reporting person's behalf to cover tax liability from vesting restricted share units; no Rule 10b5-1 plan is reported.

The report also lists direct options covering 7,476 ordinary shares at a $1.45 exercise price, expiring November 6, 2029, and 5,629 ordinary shares at a $4.17 exercise price, expiring February 17, 2032. No transactions were effected in respect of those option holdings.

Insider Trade Summary

Net Seller: 1,659 shares

Net Sell 5 txns

Insider Indave Sesma Andrea

Role VP, Human Resources

Sold 1,659 shs ($1K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares ^{F1, F2}	688	$0.79	$543.52
Sale	Ordinary Shares ^{F1, F3}	971	$0.79	$767.09
holding	Stock Option (right to buy) ^F4	--	--	--
holding	Stock Option (right to buy) ^F4	--	--	--
holding	Ordinary Shares ^F4	--	--	--

Holdings After Transaction: Ordinary Shares — 30,336 shares (Direct); Stock Option (right to buy) — 13,105 contracts (Direct)

Footnotes (4)

F1. The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
F2. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 19,830 RSUs originally granted by the Issuer to the Reporting Person that began vesting on July 15, 2024. 33.33% of such RSUs vested on the one-year anniversary of the vesting commencement date (July 15, 2025), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by the three-year anniversary of the vesting commencement date (July 15, 2027).
F3. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 28,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting on July 15, 2025. 33.33% of such RSUs vested on the one-year anniversary of the vesting commencement date (July 15, 2026), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by the three-year anniversary of the vesting commencement date (July 15, 2028).
F4. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

Key Figures

Ordinary shares sold: 688 shares Ordinary shares sold: 971 shares Sale price: $0.79 per share +4 more

7 metrics

Ordinary shares sold 688 shares Sale on October 16, 2026, to cover tax liability from RSU vesting

Ordinary shares sold 971 shares Sale on October 16, 2026, to cover tax liability from RSU vesting

Sale price $0.79 per share Each reported sale on October 16, 2026

Option underlying shares 7,476 shares Direct option holding; $1.45 exercise price; expires November 6, 2029

Option exercise price $1.45 Direct option covering 7,476 ordinary shares; expires November 6, 2029

Option underlying shares 5,629 shares Direct option holding; $4.17 exercise price; expires February 17, 2032

Option exercise price $4.17 Direct option covering 5,629 ordinary shares; expires February 17, 2032

Key Terms

restricted share units (RSUs), vesting commencement date, Stock Option (right to buy)

3 terms

vesting commencement date financial

"three-year anniversary of the vesting commencement date"

The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.

Stock Option (right to buy) financial

"Stock Option (right to buy)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CRGO shares did Sesma Andrea Indave sell?

Sesma Andrea Indave reported two sales on October 16, 2026: 688 ordinary shares and 971 ordinary shares, each at $0.79 per share. The sales were made on the reporting person's behalf to cover tax liability from vesting restricted share units; no Rule 10b5-1 plan is reported.

What RSU vesting schedules were connected to the CRGO sales?

The 688-share sale was connected to remaining shares underlying 19,830 RSUs that began vesting July 15, 2024. The 971-share sale was connected to remaining shares underlying 28,000 RSUs that began vesting July 15, 2025. For both awards, 33.33% vested on the first anniversary, with the remainder vesting equally over eight quarterly periods at 8.3325% per quarter.

What CRGO stock options are listed?

The report lists direct options covering 7,476 ordinary shares at a $1.45 exercise price, expiring November 6, 2029, and 5,629 ordinary shares at a $4.17 exercise price, expiring February 17, 2032. It states that no transactions were effected in respect of these securities and that the holdings are included for informational purposes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/20/2026 - 04:05 PM EDT Accepted by SEC EDGAR 10/20/2026 - 04:05 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Indave Sesma Andrea

(Last)

(First)

(Middle)

C/O FREIGHTOS LIMITED

PLANTA 10, AVDA. DIAGONAL, 211

(Street)

BARCELONA

08018

(City)

(State)

(Zip)

SPAIN

(Country)

2. Issuer Name and Ticker or Trading Symbol
Freightos Ltd [ CRGO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, Human Resources

2a. Foreign Trading Symbol
[N/A]

3. Date of Earliest Transaction (Month/Day/Year)
10/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	10/16/2026		S⁽¹⁾		688	D	$0.79	13,955⁽²⁾	D
Ordinary Shares	10/16/2026		S⁽¹⁾		971	D	$0.79	23,234⁽³⁾	D
Ordinary Shares⁽⁴⁾								7,102	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)⁽⁴⁾	$1.45							08/03/2023	11/06/2029	Ordinary Shares	7,476		7,476	D
Stock Option (right to buy)⁽⁴⁾	$4.17							01/01/2026	02/17/2032	Ordinary Shares	5,629		5,629	D

Explanation of Responses:

1. The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

2. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 19,830 RSUs originally granted by the Issuer to the Reporting Person that began vesting on July 15, 2024. 33.33% of such RSUs vested on the one-year anniversary of the vesting commencement date (July 15, 2025), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by the three-year anniversary of the vesting commencement date (July 15, 2027).

3. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 28,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting on July 15, 2025. 33.33% of such RSUs vested on the one-year anniversary of the vesting commencement date (July 15, 2026), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by the three-year anniversary of the vesting commencement date (July 15, 2028).

4. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

Remarks:

Exhibit 24.1 - Power of Attorney

	/s/ Max Sitnick, Attorney-in-fact	10/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR